These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11042273)
1. A potential role for p15(Ink4b) and p57(Kip2) in liver development. Awad MM; Sanders JA; Gruppuso PA FEBS Lett; 2000 Oct; 483(2-3):160-4. PubMed ID: 11042273 [TBL] [Abstract][Full Text] [Related]
2. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development. Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024 [TBL] [Abstract][Full Text] [Related]
3. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Chellappan SP; Giordano A; Fisher PB Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826 [No Abstract] [Full Text] [Related]
4. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development. Watanabe G; Pena P; Shambaugh GE; Haines GK; Pestell RG Brain Res Dev Brain Res; 1998 Jun; 108(1-2):77-87. PubMed ID: 9693786 [TBL] [Abstract][Full Text] [Related]
5. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B. Frost SJ; Simpson DJ; Farrell WE Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440 [TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671 [TBL] [Abstract][Full Text] [Related]
7. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Schwarze SR; Shi Y; Fu VX; Watson PA; Jarrard DF Oncogene; 2001 Dec; 20(57):8184-92. PubMed ID: 11781834 [TBL] [Abstract][Full Text] [Related]
8. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors. Fink JR; LeBien TW Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189 [TBL] [Abstract][Full Text] [Related]
9. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related]
10. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Schreiber M; Muller WJ; Singh G; Graham FL Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428 [TBL] [Abstract][Full Text] [Related]
13. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma. Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324 [TBL] [Abstract][Full Text] [Related]
14. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain. Joaquin M; Watson RJ J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099 [TBL] [Abstract][Full Text] [Related]
15. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells. Komata T; Kanzawa T; Takeuchi H; Germano IM; Schreiber M; Kondo Y; Kondo S Br J Cancer; 2003 Apr; 88(8):1277-80. PubMed ID: 12698196 [TBL] [Abstract][Full Text] [Related]
16. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004 [TBL] [Abstract][Full Text] [Related]
17. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462 [TBL] [Abstract][Full Text] [Related]
18. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d). Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627 [TBL] [Abstract][Full Text] [Related]
19. Negative regulators of cyclin-dependent kinases and their roles in cancers. Lee MH; Yang HY Cell Mol Life Sci; 2001 Nov; 58(12-13):1907-22. PubMed ID: 11766887 [TBL] [Abstract][Full Text] [Related]
20. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]